hoodb.com

難病ALSに白血病治療薬「ボスチニブ」が効果、患者の半数以上で進行抑える…治験は現在第2段階

|

You are leaving and open the following URL" of about "als" news

news.google.com/rss/articles/CBMiZEFVX3lxTE8zWDI2cWtfaE1TUVdVdzVQSGlacWxuYXhqYlp0R28wTmJ0QUZnVktFdm9uQUU0S0tNNGszTjFmeWhXaXNjam9JWW1STEpxMkJsVmhVN0F0TV94Z2hIRmxQbFBZTG0?oc=5


Continue Opne >

als: 難病ALSに白血病治療薬「ボスチニブ」が効果、患者の半数以上で進行抑える…治験は現在第2段階


More als news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/JP/als.xml in /var/www/hoodb/function.php on line 339
1736369192-
Warning: file_put_contents(aCache/aaa/gnews/JP//als.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About als

from
1736369193-1736286092

Warning: filemtime(): stat failed for aCache/search/jp/als in /var/www/hoodb/function.php on line 339
1736369193-

als, 難病ALSに白血病治療薬「ボスチニブ」が効果、患者の半数以上で進行抑える…治験は現在第2段階 2022 als

難病ALSに白血病治療薬「ボスチニブ」が効果、患者の半数以上で進行抑える…治験は現在第2段階

Choose Your Country or Region


Back to Top



難病ALSに白血病治療薬「ボスチニブ」が効果、患者の半数以上で進行抑える…治験は現在第2段階

Copyright © 2020-2021 hoodb.com. All Rights Reserved.